Equibles does not estimate personal net worth.
Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get YARW alertsRebecca Fry is recorded as CEO at Yarrow Bioscience, Inc. (YARW). Rebecca Fry has spoken on 2 investor events across 1 company, most recently for Yarrow Bioscience, Inc. on July 9, 2025. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO) and 7 others.
“On behalf of Yarrow, I want to thank you and the entire Vine team for your partnership as we embark on this exciting transaction. Today, we are thrilled to introduce Yarrow Bioscience and announce our planned merger with Vine Therapeutics.”
“On behalf of Yarrow, I want to thank you and the entire Vine team for your partnership as we embark on this exciting transaction. Today, we are thrilled to introduce Yarrow Bioscience and announce our planned merger with Vine Therapeutics.”
Biotechnology · Healthcare
CEO
